Gilead shares sink as the FDA rejects the company’s arthritis drug

A look at Gilead, which sank after its arthritis drug was rejected by the FDA. With CNBC’s Brian Sullivan and the Fast Money traders, Guy Adami, Tim Seymour, Bonawyn Eison and Dan Nathan.